News

---

11 September 2023

  Glasgow-based diagnostics spin-out Microplate Dx has closed a £2.5m seed funding round. 

For more information on the investment raise, please see here: 

https://www.insider.co.uk/news/microplate-dx-secures-25-million-30908929

16 March 2023

 Microplate Dx was named the winner in the Innovative Healthcare Technology category, for its work in developing a rapid, low-cost, antibiotic susceptibility test. 

For more information on the prestigious awards held in Edinburgh, Scotland on 16th March 2023, please see here: 

https://www.strath.ac.uk/whystrathclyde/news/2023/successforstrathclydespinoutatscottishlifesciencesawards/ 

07 December 2022

Microplate Dx have been selected as one of  42 businesses at the recent 20th round of Scottish EDGE who share more than £1.6million. Microplate Dx walked away with £70k to support continued business development activities. 

For more information, please see here: 

https://dailybusinessgroup.co.uk/2022/12/sturgeon-hails-firms-ability-to-adapt-to-challenges/

18 November2022

Microplate Dx have won two awards at the prestigious OBN Awards 2022 at the Royal Lancaster Hotel, London on November 17th. 

For more information and to learn about the award categories, please see here: 

https://www.obn.org.uk/news/obn-awards-2022-winners-recognised-life-sciences-industry-leading-awards-event-17-november

16 November2022

Microplate Dx have been selected as one of 24 high growth companies to pitch in the finals of the 20th round of the Scottish EDGE awards in December.

For more information, please see here: 

https://www.insider.co.uk/news/scottish-edge-award-finalists-revealed-28504767

15 September 2022

Microplate Dx have been selected as one of 12 companies to take part in the AI Accelerator, delivered by the Bayes Centre at the University of Edinburgh.

For more information, please see here: 

https://www.insider.co.uk/news/university-ai-accelerator-announces-new-27997577

12 September 2022

Microplate Dx have been selected as finalists in two categories of this year's OBN Awards 2022.   

For more information, please see here: 

https://obn.org.uk/news/obn-awards-2022-finalists-announced

1 September 2022

Microplate Dx have been selected as one of the 9 companies chosen to give an extended pitch at EIE22.

For more information, please see here: 

https://www.digit.fyi/nine-startups-chosen-for-extended-pitches-at-eie22/

1 October 2021

 A new company developing medicines for patients with debilitating chronic conditions; an innovative digital platform bringing the craft of knitting into the 21st century; a lightweight robotic glove empowering patients with hand weakness – these are just some of the ideas that triumphed at the Converge Awards, Scotland’s annual celebration of academic innovation and entrepreneurship.   

8 September 2021

 The finalists for Converge 2021, Scotland’s largest entrepreneurial development programme for the university sector, have been revealed. Exemplifying the cream of Scotland’s innovation pool, and hailing from institutions across the nation, 28 academic entrepreneurs are now through to the Converge Awards Final which takes place on 30 September 2021.

1 July 2021

A project for the development of a rapid, low-cost, antibiotic susceptibility test is among the winners in a Scotland-wide innovation showcase.

Dr Stuart Hannah, a Research Associate in Strathclyde’s Department of Biomedical Engineering and a Royal Society of Edinburgh Enterprise Fellow, won the Best Pitch award in the Converge Challenge category of Inside Innovation, in which 58 academic entrepreneurs from around Scotland made 60-second pitches for cash prizes.

10 May 2021

The Royal Society of Edinburgh (RSE), Scotland’s National Academy, has announced its latest cohort of academic entrepreneurs who have been awarded Enterprise Fellowships.

Five innovators from the science, space and technology industries have been inducted into the RSE’s Enterprise Fellowship programme, and will receive an equity-free support package worth up to £100,000 to aid in the commercialisation of their work.